We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Generics Maker Heritage Over Postmarket Reporting Woes
FDA Cites Generics Maker Heritage Over Postmarket Reporting Woes
Generic manufacturer Heritage Pharmaceuticals has been hit with a warning letter for what the FDA calls “serious violations” of postmarket reporting requirements.